Gao, B.; Zeng, S.; Maccioni, L.; Shi, X.; Armando, A.; Quehenberger, O.; Zhang, X.; Stärkel, P.; Schnabl, B.
Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder. Metabolites 2022, 12, 433.
https://doi.org/10.3390/metabo12050433
AMA Style
Gao B, Zeng S, Maccioni L, Shi X, Armando A, Quehenberger O, Zhang X, Stärkel P, Schnabl B.
Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder. Metabolites. 2022; 12(5):433.
https://doi.org/10.3390/metabo12050433
Chicago/Turabian Style
Gao, Bei, Suling Zeng, Luca Maccioni, Xiaochun Shi, Aaron Armando, Oswald Quehenberger, Xinlian Zhang, Peter Stärkel, and Bernd Schnabl.
2022. "Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder" Metabolites 12, no. 5: 433.
https://doi.org/10.3390/metabo12050433
APA Style
Gao, B., Zeng, S., Maccioni, L., Shi, X., Armando, A., Quehenberger, O., Zhang, X., Stärkel, P., & Schnabl, B.
(2022). Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder. Metabolites, 12(5), 433.
https://doi.org/10.3390/metabo12050433